# HCA Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2016

- Company: [HCA Healthcare, Inc.](/companies/hca.md) (CIK 860730)
- Form: 10-Q
- Filed: 2016-05-06
- Accepted by EDGAR: May 6, 2016, 17:16 ET
- Period: 2016-03-31
- Accession: 0001193125-16-582196
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/860730/000119312516582196/d185324d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/860730/000119312516582196/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Interest expense | 3 months, 2016-01-01 to 2016-03-31 | $416.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-01-01 to 2016-03-31 | $284.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | $694.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | $1.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-01-01 to 2016-03-31 | $1.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-01-01 to 2016-03-31 | 410,575,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | $1.40bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2016-01-01 to 2016-03-31 | $509.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2016-01-01 to 2016-03-31 | $621.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2016-03-31 | $852.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $9.20bn | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $32.78bn | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $5.40bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-03-31 | $38.77bn | us-gaap:Liabilities |
| Long-term debt | at 2016-03-31 | $30.33bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2016-03-31 | $226.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2016-03-31 | −$7.56bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 1,104 characters.

On October 26, 2015, our board of directors authorized a share repurchase program for up to $3 billion of our outstanding common stock. Repurchases made during the first quarter of 2016, as detailed below, were made through market purchases pursuant to this authorization.

The following table provides certain information with respect to our repurchases of common stock from January 1, 2016 through March 31, 2016 (dollars in millions, except per share amounts).

| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under Publicly Announced Plans or Programs |
| --- | ---: | ---: | ---: | ---: |
| January 1, 2016 through January 31, 2016 | 2,495,697 | $66.38 | 2,495,697 | $2,438 |
| February 1, 2016 through February 29, 2016 | 3,125,330 | $68.14 | 3,125,330 | $2,225 |
| March 1, 2016 through March 31, 2016 | 3,300,200 | $73.32 | 3,300,200 | $1,983 |
| Total for first quarter 2016 | 8,921,227 | $69.56 | 8,921,227 | $1,983 |

47

## Market risk

As filed, 186 characters.

The information called for by this item is provided under the caption “Market Risk” under Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

## Controls and procedures

As filed, 813 characters.

### Evaluation of Disclosure Controls and Procedures

HCA’s chief executive officer and chief financial officer have reviewed and evaluated the effectiveness of HCA’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) as of the end of the period covered by this quarterly report. Based on that evaluation, the chief executive officer and chief financial officer have concluded HCA’s disclosure controls and procedures were effective.

### Changes in Internal Control Over Financial Reporting

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

## Risk factors

As filed, 428 characters.

Reference is made to the factors set forth under the caption “Forward-Looking Statements” in Part I, Item 2 of this Form 10-Q and other risk factors described in our annual report on Form 10-K for the year ended December 31, 2015, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our annual report on Form 10-K for the year ended December 31, 2015.

Filed May 6, 2016.
Source: SEC EDGAR, the filing index for accession 0001193125-16-582196. Last ingested by Listed: Nov 11, 2026, 03:15 ET. No prices; not investment advice.
